Single‐Center Evaluation of the Myval Balloon‐Expandable Transcatheter Heart Valve: A Follow‐Up Study: A Retrospective Cohort Study
The Myval THV shows a favorable safety and efficacy profile in TAVR, with low mortality and complications at 3 months.
Authors
- Mohammad Javad Alemzadeh‐Ansari (ORCID: https://orcid.org/0000-0003-4698-3244)
- MohammadHossein MozafaryBazargany (ORCID: https://orcid.org/0000-0001-9897-6172)
- Mohammadreza Baay
- Amir Azimi (ORCID: https://orcid.org/0000-0002-8317-7009)
- Zahra Hosseini (ORCID: https://orcid.org/0000-0003-0275-2620)
- Peyman Bashghareh (ORCID: https://orcid.org/0000-0002-5512-0363)
- Armin Elahifar (ORCID: https://orcid.org/0000-0001-5667-3077)
- Ehsan Khalilipur (ORCID: https://orcid.org/0000-0001-5909-613X)
- Seifollah Abdi
- Ata Firouzi
- Amineh Safairad
Institutions
- Shaheed Rajaei Cardiovascular Medical and Research Center (IR)
Publication Details
- Journal
- Health Science Reports
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1002/hsr2.70808
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00